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One of the most exciting aspects of the
genomic era during the last fifteen years
has been the discovery of RNA interfer-
ence pathways and their key function in
gene regulation in eucaryotes. RNAi has
rapidly invaded our laboratories and has
become the gold standard technique to
investigate the function of a given gene. In
parallel, intensive research on microRNAs
(miRNAs) has underlined their wide roles
in development, homeostasis and diseases
processes. However, the road toward the
therapeutic use of RNAi in human has
proven to be more tortuous than antici-
pated with difficulties in minimizing sev-
eral off-target effects, and it is becoming
clear that this strategy can only succeed in
a limited number of diseases at present.
As underlined in the preface, the edi-
tors, Patrick Arbuthnot and Marc S.
Weinberg do not aim to propose a com-
prehensive book describing the large back-
ground in the field and general protocols
for gene silencing, as already performed by
several authors but have rather chosen to
highlight some of the most exciting aspects
of current RNAi research. Indeed, the book
is organized in twelve chapters focused on
different subjects ranging from fundamen-
tal biological aspects to specific topics on
RNAi-based therapy.
Chapter I, “Overview of biogenesis and
applications of miRNA” by Arbuthnot and
Weinberg is an excellent introduction to
the field. The authors review precisely
and concisely all the aspects of miRNA
biogenesis and the discoveries concern-
ing miRNA function and role in cell and
organs as well as their wide potential ther-
apeutic applications.
The second Chapter, “Non-canonical
miRNA biogenesis and function” describes
the different forms of non-canonical bio-
genesis of miRNAs as well as new emergent
families of small RNAs. This chapter also
addresses non-canonical miRNA func-
tions such as activation of translation
or transcriptional gene regulation and
discusses recent investigations regarding
interactions between miRNAs and long
non-coding RNAs and the potential role
of miRNAs in the extracellular envi-
ronment. A third chapter “Non-coding
RNAs and the Epigenetic Control of Gene
Expression” logically pursues this descrip-
tion about the emerging concept of a
RNA-based epigenetic regulatory network
whilst remaining quite superficial on these
issues. This more fundamental section
appears complete and overall well orga-
nized, with minimal overlap on general
principles governing miRNA biogenesis
and functions.
Having presented this detailed
background on the subject, the following
chapters deal with RNAi and miRNA tech-
nologies. Chapter 4, “From mice to men:
toward the clinical translation of miRNA
technologies for somatic cell reprogram-
ming” is a very interesting section, not
only describing the role of miRNA in iPS
generation but also the approaches that
have been developed by different groups
to identify miRNAs involved in pluripo-
tency and their potential use as new tools
in regenerative medicine.
Three chapters focus on RNAi, miRNAs
and virus infection, covering very differ-
ent, yet complementary fields with focus
on “Systems biology tools to understand
the role of host miRNAs in infection”
(chapter 5), a review on “Harnessing RNAi
for the Treatment of Viral Infections”
(chapter 9) and a specific chapter on
“Roles of miRNAs in Cancers Associated
with Human Tumor Viruses (chapter 10).
Because RNAi represents an ancestral cel-
lular defense mechanism against vari-
ous viruses, whilst on the other hand
many viruses express their own miRNAs,
this section provides a very interesting
and quite complete picture of the com-
plex defense and counterattack molecu-
lar mechanisms developed by cells and
viruses. The authors also underline the
efforts to improve delivery and decrease
unwanted side effects of RNAi as thera-
peutic tools against virus, which may soon
provide efficient weapons against devastat-
ing diseases such as the current Ebola virus
outbreak.
A specific chapter (chapter 11) is
devoted to “MiRNAs as cancer biomark-
ers” giving a good overview of the
considerable interest in this field. It would
however have been important here to
strongly warn against the heterogene-
ity of the studies reporting circulating
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miRNA cancer biomarkers because of sev-
eral potential technical biases.
The following chapter (chapter
12) describes the role of miRNAs
in Trinucleotide Repeat Expansion
Disorders. The common basis of these
diseases is the presence of an expanded
sequence in the protein or in the mRNA,
but the function of the genes that are
involved is very different as well the brain
regions that are involved in the disorder.
For this reason, the main interest of the
role of miRNAs in these kinds of disorders
is the possibility to use them for down-
regulation of the abnormal transcripts
that are the cause of neurodegeneration.
Given the number of studies on the
role of miRNAs in cancer and nervous sys-
tem, it is however frustrating not to find
additional information on these key top-
ics, for example, the relevance of those
molecules in the formation and plasticity
of the synapse with potential implication
in neurological and psychiatric disorders.
Finally, a key section of the book cor-
responds to three chapters dealing with
“Synthetic miRNA Blocking Agents”
(chapter 6), “Exploiting miRNAs to
Regulate Transgene Expression” (chapter
7) and “Use of Artificial miRNAs for Gene
Silencing” (chapter 8) that very clearly
describe and discuss the various exper-
imental and therapeutic applications of
miRNAs. The chapter related to miRNA
blocking agents offers a very complete
and precise view of this complex area and
should be read by any investigator initiat-
ing in vitro or in vivo studies with miRNA
inhibitors.
In conclusion, this book is well written,
each chapter is not too long and in general
the reading is easy with a few discrepan-
cies between the quality of the different
sections as mentioned above. Overall we
believe that this book can be very useful for
students as well for researchers starting to
work in this subject. Some basic studies on
this subject are well developed, the main
applications and limitations of RNAi and
miRNA-base technology are presented and
a large amount of literature is summarized
in tables, simplifying the search of studies
of interest.
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